Atlas Trials

Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction

Clinical trial NCT04369534 · COMPLETED

Trial details

NCT number
NCT04369534
Sponsor
University of Zagreb
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acute Coronary SyndromeSTEMINSTEMI - Non-ST Segment Elevation MIPLATELET AGGREGATIONINDIVIDUALIZED THERAPY
Start date
2015-12-01
Primary completion
2019-11-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.